Industry Programs are a promotional activity and are not approved for continuing education credit unless otherwise noted. The content and opinions expressed by presenters are those of the sponsor or presenter and are not supported, endorsed, or accredited by the American Thoracic Society.
Browse Event Schedules by Type:
Product Theater for Zepbound® (tirzepatide) Injection
Innovation Theater 4
Sponsored by: Eli Lilly and Company
A Closer Look at Single Inhaler Triple Therapy for COPD and Latest Real-World Evidence
Innovation Theater 1
Sponsored by: GSK
“I Want to Breathe Better”: Help Appropriate Uncontrolled Asthma and COPD Patients
Innovation Theater 4
Sponsored by: Sanofi | Regeneron
Unraveling the Complexity: Managing Multiple Triggers and Drivers of Inflammation in Severe Asthma
Innovation Theater 3
Sponsored by: Amgen/AstraZeneca
AIRSUPRA® (albuterol 90 mcg/budesonide 80 mcg): The Paradigm Is Shifting
Innovation Theater 5
Sponsored by: AstraZeneca
Mapping COPD Exacerbation: Understanding Outcomes and Impact of Hospital Visits on the Path to One Goal
Innovation Theater 2
Sponsored by: GSK
Closing the Gap: Improving Diagnosis in the U.S. Cystic Fibrosis Population
Innovation Theater 1
Sponsored by: Vertex Pharmaceuticals, Inc.
Evidence for the Role of IL-5 in Severe Eosinophilic Asthma
Innovation Theater 2
Sponsored by: GSK
A Novel Inhaled PDE3/PDE4 Inhibitor for the Maintenance Treatment of COPD in Adults
Innovation Theater 4
Sponsored by: Verona Pharma Inc.
Cracking the Case: Interactive Insights on Collaborative Care in Interstitial Lung Disease Diagnosis
Innovation Theater 3
Sponsored by: Boehringer Ingelheim Pharmaceuticals, Inc.
A Fresh Perspective on Airway Diseases: Connecting Epithelial Cytokines in Severe Asthma, CRSwNP, and COPD
Innovation Theater 5
Sponsored by: Amgen/AstraZeneca
SyMMPonia: A Phase 2 Study of Linvemastat (FP-020) in Uncontrolled Asthma
Innovation Theater 1
Sponsored by: Foresee Pharmaceuticals
Problem Based Learning: Type 2 Inflammation in COPD
Innovation Theater 4
Sponsored by: Sanofi | Regeneron
Dyspnea in COPD: Clearing the Air on Effective Management
Innovation Theater 1
Sponsored by: Verona Pharma Inc.
Eosinophils in COPD: A Biomarker of Type 2 Inflammation to Predict Therapeutic Response
Innovation Theater 4
Sponsored by: Sanofi | Regeneron
Clearing the Air on Bronchiectasis Exacerbations: Burden, Causes, and Management of Exacerbations
Innovation Theater 3
Sponsored by: Insmed Incorporated
One Approach, Many Patients: Addressing Eosinophilic Inflammation
Innovation Theater 5
Sponsored by: AstraZeneca
Breathe Easier: Can We Do More to Improve Management of Adult Patients With Asthma?
Innovation Theater 2
Sponsored by: GSK
Persistent Airflow Obstruction: Elucidating the Impact of Eosinophilic Inflammation
Innovation Theater 1
Sponsored by: Amgen/AstraZeneca
Patient Cases for the Chronic Treatment of Adults with PAH
Innovation Theater 2
Sponsored by: Johnson & Johnson
GSK Respiratory Biologic Product Theater
Innovation Theater 4
Sponsored by: GSK
Triple Therapy in Focus: The Importance of a Proactive Approach
Innovation Theater 3
Sponsored by: AstraZeneca
Finding the Space to Breathe: Harnessing NASA’s Data to Improve Respiratory Health
Innovation Theater 5
Sponsored by: Chiesi USA
Decoding Inflammation in COPD: New Insights and Opportunities
Innovation Theater 1
Sponsored by: Genentech
IL-33 in COPD: Two Sides to the Story
Innovation Theater 1
Sponsored by: AstraZeneca
SANOFI Why Respiratory Vaccines Are Still Important: The Current Challenges & Opportunities in Pertussis, COVID-19 and Influenza Vaccination
Innovation Theater 4
Sponsored by: Sanofi
Many Paths, One Goal: Collaborative COPD Care for Patients with Type 2 Inflammation
Innovation Theater 3
Sponsored By: GSK
Taking Control: The Urgent Need to Identify and Address Uncontrolled Asthma
Innovation Theater 5
Sponsored by: AstraZeneca
Breathing New Life: Inhaled Nintedanib and the Future of Pulmonary Fibrosis Treatment
Innovation Theater 2
Sponsored by: Avalyn Pharma
Pulmonologist & Cardiologist Live: A Collaborative Approach to Cardiopulmonary Risk in COPD
Innovation Theater 1
Sponsored by: AstraZeneca
Expert Discussion: Emerging Evidence on a PAH Treatment
Innovation Theater 4
Sponsored by: Johnson & Johnson
Airway Inspection: A Routine Task OR a Lifesaving Event?
Pinnacle Biologics Inc.
Innovation Theater 2
Advances in Autoimmune Pulmonary Alveolar Proteinosis
Innovation Theater 3
Sponsored by: Savara Inc.
Evolving Our View of COPD: Sounding the Alarm on Chronic Inflammation
Innovation Theater 2
Sponsored by: Sanofi | Regeneron
Cough and Effect: Diagnosing Refractory Chronic Cough with Speed and Precision
Innovation Theater 1
Sponsored by: GSK